These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24633814)

  • 1. Effects of CDNF on 6-OHDA-induced apoptosis in PC12 cells via modulation of Bcl-2/Bax and caspase-3 activation.
    Mei JM; Niu CS
    Neurol Sci; 2014 Aug; 35(8):1275-80. PubMed ID: 24633814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective and reversal effects of conserved dopamine neurotrophic factor on PC12 cells following 6-hydroxydopamine administration.
    Mei J; Niu C
    Mol Med Rep; 2015 Jul; 12(1):297-302. PubMed ID: 25738732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells.
    Guo DJ; Li F; Yu PH; Chan SW
    Pharm Biol; 2013 Feb; 51(2):190-6. PubMed ID: 23035972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligustrazine suppresses neuron apoptosis via the Bax/Bcl-2 and caspase-3 pathway in PC12 cells and in rats with vascular dementia.
    Zhao T; Fu Y; Sun H; Liu X
    IUBMB Life; 2018 Jan; 70(1):60-70. PubMed ID: 29247598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells.
    Pišlar AH; Zidar N; Kikelj D; Kos J
    Neuropharmacology; 2014 Jul; 82():121-31. PubMed ID: 23958447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model.
    Ren X; Zhang T; Gong X; Hu G; Ding W; Wang X
    Exp Neurol; 2013 Oct; 248():148-56. PubMed ID: 23764500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
    Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
    Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-beta-hydroxybutyrate inhibits the apoptosis of PC12 cells induced by 6-OHDA in relation to up-regulating the ratio of Bcl-2/Bax mRNA.
    Cheng B; Yang X; Hou Z; Lin X; Meng H; Li Z; Liu S
    Auton Neurosci; 2007 Jul; 134(1-2):38-44. PubMed ID: 17369104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action.
    Voutilainen MH; De Lorenzo F; Stepanova P; Bäck S; Yu LY; Lindholm P; Pörsti E; Saarma M; Männistö PT; Tuominen RK
    eNeuro; 2017; 4(1):. PubMed ID: 28303260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key Subdomains of Cerebral Dopamine Neurotrophic Factor Regulate Its Protective Function in 6-Hydroxydopamine-Lesioned PC12 Cells.
    Liu H; Dong H; Wang C; Jia W; Wang G; Wang H; Zhong L; Gong L
    DNA Cell Biol; 2023 Nov; 42(11):680-688. PubMed ID: 37815547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin attenuates 6-hydroxydopamine-induced apoptosis via glycogen synthase kinase 3β-mediated mitochondrial translocation of Bax in PC12 cells.
    Ge XH; Zhu GJ; Geng DQ; Zhang ZJ; Liu CF
    Neurol Sci; 2012 Dec; 33(6):1249-56. PubMed ID: 22294054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistin protects against 6-hydroxydopamine-induced cell death in dopaminergic-like MES23.5 cells.
    Lu DY; Chen JH; Tan TW; Huang CY; Yeh WL; Hsu HC
    J Cell Physiol; 2013 Mar; 228(3):563-71. PubMed ID: 22806254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease.
    Voutilainen MH; Bäck S; Peränen J; Lindholm P; Raasmaja A; Männistö PT; Saarma M; Tuominen RK
    Exp Neurol; 2011 Mar; 228(1):99-108. PubMed ID: 21185834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of vitamin K2 on 6-OHDA-induced apoptosis in PC12 cells through modulation bax and caspase-3 activation.
    Ramazani E; Fereidoni M; Tayarani-Najaran Z
    Mol Biol Rep; 2019 Dec; 46(6):5777-5783. PubMed ID: 31392537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory ensheathing cells conditioned medium prevented apoptosis induced by 6-OHDA in PC12 cells through modulation of intrinsic apoptotic pathways.
    Feng L; Meng H; Wu F; Cheng B; He X; Wang X; Li Z; Liu S
    Int J Dev Neurosci; 2008; 26(3-4):323-9. PubMed ID: 18295431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of engineered conserved dopamine neurotrophic factor-expressing bone marrow stromal cells on dopaminergic neurons following 6-OHDA administrations.
    Mei J; Niu C
    Mol Med Rep; 2015 Feb; 11(2):1207-13. PubMed ID: 25373844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP.
    Lu C; Zhang J; Shi X; Miao S; Bi L; Zhang S; Yang Q; Zhou X; Zhang M; Xie Y; Miao Q; Wang S
    Int J Biol Sci; 2014; 10(4):350-7. PubMed ID: 24719552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties.
    Olatunji OJ; Feng Y; Olatunji OO; Tang J; Ouyang Z; Su Z
    Biomed Pharmacother; 2016 Jul; 81():7-14. PubMed ID: 27261571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration.
    Oh CK; Han BS; Choi WS; Youdim MB; Oh YJ
    Apoptosis; 2011 Nov; 16(11):1087-100. PubMed ID: 21739275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease.
    Latchoumycandane C; Anantharam V; Jin H; Kanthasamy A; Kanthasamy A
    Toxicol Appl Pharmacol; 2011 Nov; 256(3):314-23. PubMed ID: 21846476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.